JPMorgan reports a passive stake above 5% in REGENXBIO (RGNX).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
JPMorgan Chase & Co. has reported a passive beneficial ownership stake of 5.3% in REGENXBIO Inc. (RGNX), amounting to 3,560,915 shares, as of September 30, 2026. The filing indicates JPMorgan holds sole voting power over 3,324,340 shares and sole dispositive power over all 3,560,915 shares. This disclosure was made via a SCHEDULE 13G SEC filing, signifying a passive investment.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.